## Abstract Cancer cachexia is a morbid wasting syndrome common among patients with head and neck cancer. While its clinical manifestations have been well characterized, its pathophysiology remains complex. A comprehensive literature search on cancer cachexia was performed using the National Librar
Cancer cachexia syndrome in head and neck cancer patients: Part I. Diagnosis, impact on quality of life and survival, and treatment
โ Scribed by Marion Couch; Victor Lai; Trinitia Cannon; Denis Guttridge; Adam Zanation; Jonathan George; D. Neil Hayes; Steven Zeisel; Carol Shores
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 191 KB
- Volume
- 29
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Background
Cancer cachexia is a debilitating, wasting condition that affects many cancer patients, including those with head and neck cancer. The overall incidence of cancer cachexia is quite high for some types of cancer, and cachexia will be the main cause of death for more than 20% of all cancer patients. This syndrome uniquely challenges patients with head and neck cancer. This article outlines the diagnosis of cancer cachexia, reviews its impact on patient quality of life (QOL) and survival, and updates the reader on potential therapies that may suppress it.
Methods
A comprehensive literature search was performed using PubMed of the National Library of Medicine, which includes more than 15 million citations back to the 1950s. The Cochrane Library and Google search engine were used as well.
Results
This syndrome differs significantly from starvation, and thus accurate and timely diagnosis is essential. Nutritional therapy alone is insufficient. Current management strategies include corticosteroids and megesterol acetate, in conjunction with nutritional therapy. Future strategies may include nutraceuticals, omegaโ3 fatty acids, inflammatory antagonists, and other targeted treatments.
Conclusions
Because cancer cachexia differs significantly from starvation, nutritional supplementation must be used in conjunction with other antiโcachexia agents to reverse the chronic systemic inflammatory state and the effects of circulating tumorโderived factors seen in cachexia. Careful identification of patients at risk and those suffering from this syndrome will lead to better outcomes and treatments. Ultimately, more research is needed to better treat this devastating condition. ยฉ 2007 Wiley Periodicals, Inc. Head Neck, 2007
๐ SIMILAR VOLUMES
## Abstract ## Background. Little is known about quality of life (QOL) in elderly patients. ## Methods. Seventyโeight older (โฅ70 years) and 105 younger patients (45โ60 years) with carcinoma of the oral cavity, pharynx (stage โฅII), or larynx (stage โฅIII) completed the European Organization for Re
## Abstract ## Background. Xerostomia is a common, debilitating complication of radiation therapy (RT) for head and neck cancer. This article reviews the pathogenesis of radiationโinduced xerostomia, its impact on quality of life (QOL), and treatment options. ## Methods. Virtually all patients u
## Background: Psychological and physical stresses from head and neck cancer can be substantial for patients and partners. there is minimal research exploring treatment impact, particularly facial disfigurement after surgery. ## Materials and methods: Twenty-eight surgery and radiotherapy/brachyt
## Abstract ## Background. A longitudinal, prospective, caseโcontrol study evaluated if a psychosocial support program improved healthโrelated quality of life (HRQL) in head and neck (H&N) cancer patients. ## Methods. One hundred fortyโfour H&N cancer patients were included: 52 study patients an
## Abstract ## Background In 2001, we presented a Cox regression model that is able to predict survival of the newly diagnosed patient with head and neck squamous cell carcinoma (HNSCC). This model is based on the TNM classification and other important clinical variables such as age at diagnosis,